.RESEARCH STUDY EMPHASIZE.06 August 2024.
A sizable randomized controlled test along with cisgender women highlights the problems of adherence to an everyday oral preexposure prophylaxis routine and illustrates that twice-yearly treatment of lenacapavir may preserve helpful HIV prevention levels over 6 months.